Cholera/enterotoxigenic escherichia coli vaccine (Celldex Therapeutics)

N/A

Report date: 2022/01/20 10:36:21

Base Information

Drug NameCholera/enterotoxigenic escherichia coli vaccine (Celldex Therapeutics)

Drug Alias NamePeru-15 pCTBCholera/ETEC vaccineETEC/cholera vaccineCombined live, attenuated, enterotoxigenic Escherichia coli (ETEC)-cholera Vaccine (Peru-15 pCTB) (Celldex Therapeutics/NIAID)Traveller's diarrhoea vaccine (Celldex Therapeutics)

ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsGastroenteritisCholeraEscherichia coli Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Celldex Therapeutics

China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)

Inactive CompaniesN/A

Active IndicationsCholera

Inactive IndicationsGastroenteritisEscherichia coli Infections

Other Information

ATC CodeN/A